Co-founder & CEO
Shares before the IPO: 2 533 500
Former Vice President of Marketing & Strategy @ world’s largest wind energy co. 5 years @ Boston Consulting Group. M.Sc. Management of Technology, CBS Cognitive Psychology studies, UCPH. Healthcare Innovation degree HARVARD Business School (Pasteur Program).
Chief Science & Innovation Officer
12 years of experience as a biomedical engineer.
Experience from several medtech startups
Senior scientist & team mgr. at Coloplast.
Postdoc, Cognitive Neuroscience, University of Copenhagen.
PhD. Cognition and psychophysics, DTU.
HANNE LETH HILLMAN
Interim Chief Financial Officer
Experienced life science executive focused on finance, communications and investor relations (IR) M.Sc. (Cand.Merc.Int), Business Administration and International Finance supplemented with a diploma in International Money and Finance – The Aarhus University School of Business and Social Sciences. Board leadership education from CBS Executive.
Bertil Stengaard Jessen
Chief Financial Officer (Absent from May 2023 for family reasons)
Former head of a global strategic investment program at GN Store Nord. Corporate strategy and M&A advisory at Maersk and J.P. Morgan’s investment banking division.
MSc in Economics and Business Administration – Applied Economics and Finance from Copenhagen Business School.
BOARD OF DIRECTORS
Chairman since Sep. 2022
Chairman at Diurnal Group (DNI) and Non-Executive Director at Prothena Corporation (PRTA)
35 years of experience and a sustained successful global track record within global business development and new product commercialization in biotech and pharma.
Board member since Sep. 2022
EVP & Head of R&D at Lundbeck
30 years’ experience of pharmaceutical industry research and development in companies such as Lundbeck, Eisai US and Merck.
Board member since Oct. 2023
13+ years of experience from leading positions in digital care, digital acceleration, and DTx with Biogen, Novartis and Sanofi. He has executed 30+ Biotech/Pharma-HealthTech partnerships, co-developments, collaborations; & investments.
Keswick Global AG
A 1120 Vienna, Austria
+43 1 740 408045